REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England
View ORCID ProfileSteven Riley, View ORCID ProfileHaowei Wang, View ORCID ProfileOliver Eales, View ORCID ProfileCaroline E. Walters, View ORCID ProfileKylie E. C. Ainslie, View ORCID ProfileChristina Atchison, Claudio Fronterre, View ORCID ProfilePeter J. Diggle, View ORCID ProfileDeborah Ashby, View ORCID ProfileChristl A. Donnelly, View ORCID ProfileGraham Cooke, View ORCID ProfileWendy Barclay, View ORCID ProfileHelen Ward, View ORCID ProfileAra Darzi, View ORCID ProfilePaul Elliott
doi: https://doi.org/10.1101/2021.01.20.21250158
Steven Riley
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Haowei Wang
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Oliver Eales
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Caroline E. Walters
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Kylie E. C. Ainslie
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
12Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
Christina Atchison
1School of Public Health, Imperial College London, UK
Claudio Fronterre
3CHICAS, Lancaster Medical School, Lancaster University, UK and Health Data Research, UK
Peter J. Diggle
3CHICAS, Lancaster Medical School, Lancaster University, UK and Health Data Research, UK
Deborah Ashby
1School of Public Health, Imperial College London, UK
Christl A. Donnelly
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
4Department of Statistics, University of Oxford, UK
Graham Cooke
5Department of Infectious Disease, Imperial College London, UK
6Imperial College Healthcare NHS Trust, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
Wendy Barclay
5Department of Infectious Disease, Imperial College London, UK
Helen Ward
1School of Public Health, Imperial College London, UK
6Imperial College Healthcare NHS Trust, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
Ara Darzi
6Imperial College Healthcare NHS Trust, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
8Institute of Global Health Innovation at Imperial College London, UK
Paul Elliott
1School of Public Health, Imperial College London, UK
6Imperial College Healthcare NHS Trust, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
9MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
10Health Data Research (HDR) UK London at Imperial College
11UK Dementia Research Institute at Imperial College
Article usage
Posted January 22, 2021.
REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England
Steven Riley, Haowei Wang, Oliver Eales, Caroline E. Walters, Kylie E. C. Ainslie, Christina Atchison, Claudio Fronterre, Peter J. Diggle, Deborah Ashby, Christl A. Donnelly, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Paul Elliott
medRxiv 2021.01.20.21250158; doi: https://doi.org/10.1101/2021.01.20.21250158
REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England
Steven Riley, Haowei Wang, Oliver Eales, Caroline E. Walters, Kylie E. C. Ainslie, Christina Atchison, Claudio Fronterre, Peter J. Diggle, Deborah Ashby, Christl A. Donnelly, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Paul Elliott
medRxiv 2021.01.20.21250158; doi: https://doi.org/10.1101/2021.01.20.21250158
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)